Aratana Therapeutics (PETX) PT Raised to $26 at BofA/Merrill Lynch
Tweet Send to a Friend
BofA/Merrill Lynch analyst Erin Wilson raised her price target Buy-rated Aratana Therapeutics (NASDAQ: PETX) to $26.00 (from $25.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
